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Background: The impact of paraoxonase-1 (PON1) activity on the efficacy of clopidogrel has not been clarified. The aim of this study was to assess 
the impact of PON1 activity on the incidence of intra-stent thrombus (IS Th) after drug-eluting stent (DES) implantation in the Japanese CYP2C19 
loss of function polymorphism carriers (LOF carriers) and non-carriers receiving clopidogrel.
Method: This study included 96 Japanese patients receiving clopidogrel (75mg/day) and aspirin (100mg/day) who underwent optical coherence 
tomography (OCT) examination for the evaluation of IS Th 8 months after DES implantation. CYP2C19 genotype was analyzed and LOF carrier 
(*1/*2, *1/*3, *2/*2, *3/*3, *2/*3) was identified. PON1 activity was evaluated by spectrophotometric assay, using paraoxon as a substrate.
Result: Sixty five patients (67.7%) were LOF carriers. The median PON1 activity was 243 U/L. In both LOF carriers and non-carriers, the patients 
were divided into High PON 1 (PON1 activity was equal or above 243 U/L) and Low PON 1 (below 243 U/L) groups. IS Th was observed more 
frequently in LOF carriers compared with non-carriers. Among LOF carriers, IS Th was more frequent in Low PON 1 group than High PON 1 group.
Conclusion: This study found that the CYP2C19 LOF is associated with higher frequency of intra-stent thrombus. There seems to be interactions 
between CYP2C19 and PON1 activity on the clopidogrel efficacy, which may have a clinical impact among Japanese patients receiving clopidogrel 
after DES implantation.
 
